$1.03
▲ +1.5% Today
as of Sep 4, 16:53 ET
Last 30 days
Recent Press Releases & News
Propanc Biopharma Reports PRP Preclinical Pancreatic Cancer Data Showing Over 90% Tumor Growth Inhibition
Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit
Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP
Overview
52-week range
$0.95
$62
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-10.7%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.28 | — | — | +97.8% | -21.4% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $-0.30 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.39 | — | — | — | — | financials |
| Thu May 15, 2025 | Mar/2025 | $-12.50 | — | — | — | 0.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-35.97 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-545.79 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-1559.55 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.04 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.42 | — | — | — | — | financials |
| Sat Dec 31, 2022 | Dec 2022 | $-0.53 | — | — | — | — | financials |
| Fri Sep 30, 2022 | Sep 2022 | $-2.13 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-6M | $-4M | $-5M | — | — | — | $-290,790 | — |
| Net income | $-6M | $-3M | — | — | — | — | — | — |
| EPS (diluted) | $-0.28 | $-0.30 | $-0.39 | — | — | — | $-35.97 | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | $602,737 | — | $50,760 | $14,633 | $9,268 | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $8M | $8M | $9M | $8M | $10M | $17,984 | $21,534 | $25,441 |
| Total assets | $14M | $15M | $18M | $20M | $23M | $78,533 | $63,644 | $72,365 |
| Long-term debt | $55,000 | $55,000 | $106,968 | $537,921 | $438,578 | $409,799 | $381,789 | $399,325 |
| Total liabilities | $4M | $4M | $4M | $6M | $4M | $4M | $4M | $4M |
| Total equity | $10M | $10M | — | $14M | — | — | — | $-4M |
Implied volatility — last 90 days
No IV snapshots yet for PPCB.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.